•Experienced in market sizing, competitive landscape, market research, segmentation, value proposition, journey maps, KOL engagement, congress support, forecasting, budgeting, advocacy and PR.•Expertise in packaging, and logo design, target product profiles (TPP), scientific narrative, campaign development, congress support, advisory boards, digital engagement (website development, SEO, programmatic email, social media, multi and omnichannel).•Deep experience across numerous therapeutic areas including Cardiovascular, Oncology, Asthma and Allergy, Dermatology, Women’s Health, Rare and Orphan diseases.

Project lead to the CLT responsible for medical affairs communications technology enabled services targeting HCPs.•Developed comprehensive go to market strategies and implementation plans of both new and existing products.•Supported the sales team in driving brand awareness and adoption across key customer segments, including presentation decks, case studies, demo’s, videos, product fact sheets and training materials.•Lead competitive intelligence and assessed landscape to develop insights that inform strategic decision-making.•Established process for assessing use cases and build business case ex. Data as a Product, Publication benchmarking and generative AI for publication content optimization.•Evaluate cutting-edge SaaS and data software solutions, applying a rigorous business approach within the incubation hub to drive successful development and implementation.

Product Owner responsible for BPO commercial platforms that provide remote engagement to HCPs and patients.•Oversaw the modernization of IntelliHealth, the commercial platform, transitioning to Salesforce, a scalable cloud infrastructure that prioritized integration, cost reduction, and operational efficiency, while sunsetting legacy system.•Contribution margins increased to +12% by finding efficiencies in technology.•Developed strategies for omnichannel solutions with API open garden integrations to open data sources, AdTech and MarTech systems supported by marketing automation tools for channel optimization and personalized engagement.•Developed roadmaps, user stories, technical requirements, to enhance sales and marketing effectiveness.•Designed comprehensive dashboards utilizing data visualization tools such Power BI for actionable HCP insights.•Partnered with sales to provide consultative support to clients and developed promotional sales tools, demo’s, training, and marketing content, RFPs responses and pitch support.•Advisor to GM and senior leaders on changing market dynamics and trends regarding new capabilities such as analytics and omnichannel service offerings, including CRM, CDP, ML/AI, journey orchestration and automation.•Provided thought leadership through webinars, blogs, and white papers.

Successfully led the commercial launch of Imvexxy, the company's first therapeutic product in the women's health sector, which significantly expanded their market reach, increased brand visibility, demonstrated value to investors, and enhanced the company's market valuation.Responsiblilities:•Developed the integrated strategic marketing plan and go to market approach •Led brand name, pricing, value proposition, packaging, logo, positioning, campaign, and execution•Led opinion leader mapping, established relationships with key customers•Partnered with patient engagement team to implement telemedicine, pharmacy services and affordability programs through VitaCare, a non-dispensing pharmacy •Recruited and developed team of three direct reports

Launched Praluent, a first in class PCSK9 (monoclonal antibody) into the marketplace •Developed and coordinated the U.S. HCP launch to develop the go to market approach•Partnered with global commercial/medical teams across the alliance (Regeneron) •Negotiated and aligned on mutually beneficial interests with key customers (ACC, NLA, ENDO) and KOL’s

Launched Jevtana, the first in class treatment for 2L prostate cancer. First year sales exceeded 106% of plan.•Developed and executed marketing launch campaigns, led competitive action plan, scenario planning, customer segmentation, and maintained key advocacy partner relationships including a multi partnership PR campaign for patient awareness. Partners included Amgen, ESPN and ASCO

Led the strategy and execution for the Coalition to Prevent DVT to raise awareness of DVT with patients, HCP’s and policymakers. Partnered with policy and advocacy teams to achieve the Coalition goals which included introducing national DVT screening day on Capitol Hill, OSG Call to Action, JC/NQF endorsing quality measures.•Developed hospital marketing approaches to shift purchasing decisions based solely on acquisition costs of therapy to the cost associated with the consequences of not treating with appropriate therapy.•Developed promotional tools and programs and partnered with the institutional and national account teams leveraging risk assessment models and tools for use with P&T members, and to support contracting initiatives and field sales teams.•Developed patient discharge kit to ensure patients discharged received Lovenox and developed educational programs for patients in hospital. •Led consumer strategy and operating plan, including digital and print DTC, DTP campaigns•Lead cross functional teams and vendors; budget management ($22M at peak)Key successes •Received Pinnacle Award (2007) and TWIN award (2010) •Awareness of DVT increased, 24% unaware of DVT in 2003 vs 46% in 2009•Grew Coalition membership to more than 70 members
•Coalition to Prevent DVT supported the need for and development of the quality managers (QIM’s)

Group Account Supervisor (Advair Diskus $2.9B)Account ManagementLed and Developed Direct ReportsLead cross functional teams in the development of all promotional campaigns from developing market research plan leading to insight discovery, refining promotional strategy, data mining, message and creative development to development of all promotional materials Launched 2 new indications within 6 months of one another and facilitated the utilization of new and out of the box innovative thinking

Product Manager Nasonex ($433M) Nov 2001 - Feb 2003Developed and implemented professional campaignsResponsibilities included market analysis, financial modeling and forecasting, business plan development, strategic direction, tactical development and implementationDeveloped and implemented market expansion opportunities Evolved and executed a conversion plan from pseudoephedrine containing Schering Rx products to NIS (Nasonex) for congestion. Incremental market potential is $67M dollarsDeveloped and implemented launch plan for pediatric indication having potential to increase market by 2%Lead cross - functional teams Sr. Business Information Analyst Jan 1999 – Nov 2001Liaison to Schering Oncology Biotech Business Unit. Responsibilities included identifying new opportunities for revenue through data mining and ad - hoc analysis in support of marketing needs. Resulted in the carve out of a new business unit within Oncology with $143 million dollar potential opportunity by targeting PCP’s to increase awareness, screening and referrals for Hepatitis C patients Business Development and Sales Oct 1994 – Jan 1999Specializing in Allergy, asthma, anti – infective and dermatological products Consistently ranked in the top 20% nationwide for sales growth

Managed day to day operations in preparation for global launch

Sales RepresentativeSpecializing in Female Healthcare ProductsAchieved #3 ranking regionally for Norplant salesMaintained an overall ranking for all product groups in top 30% nationwide